Literature DB >> 25072794

Hemolysis exacerbates hyperfibrinolysis, whereas platelolysis shuts down fibrinolysis: evolving concepts of the spectrum of fibrinolysis in response to severe injury.

Hunter B Moore1, Ernest E Moore, Eduardo Gonzalez, Kirk C Hansen, Monika Dzieciatkowska, Michael P Chapman, Angela Sauaia, Bernadette West, Anirban Banerjee, Christopher C Silliman.   

Abstract

INTRODUCTION: We have recently identified a spectrum of fibrinolysis in response to injury, in which there is increased mortality in patients who have either excessive fibrinolysis (hyperfibrinolysis [HF]) or impaired fibrinolysis (shutdown). The regulation of the fibrinolytic system after trauma remains poorly understood. Our group's previous proteomic and metabolomic work identified elevated red blood cell (RBC) degradation products in trauma patients manifesting HF. We therefore hypothesized that hemolysis was contributory to the pathogenesis of HF. Given the central role of platelets in the cell-based model of coagulation, we further investigated the potential role of platelet lysis in mediation of the fibrinolytic system.
METHODS: Red blood cells from healthy donors were frozen in liquid nitrogen and vortexed to create mechanical membrane disruption. Platelets were prepared in a similar fashion. Assays were performed with citrated whole blood mixed ex vivo with either RBC or platelet lysates. Tissue plasminogen activator (tPA) was then added to promote fibrinolysis, mimicking the tPA release from ischemic endothelium during hemorrhagic shock. The degree of fibrinolysis was evaluated with thromboelastography. To identify the mediators of the fibrinolysis system present in RBC and platelet lysates, these lysates were passed over immobilized tPA and plasminogen affinity columns to capture protein-binding partners from RBC or platelet lysates.
RESULTS: The addition of 75 ng/mL of tPA to whole blood increased fibrinolysis from median 30-min lysis of 1.4% (interquartile range [IQR], 0.9%-2.0%) to 8.9% (IQR, 6.5%-11.5%). Red blood cell lysate with tPA increased fibrinolysis to 20.1% (IQR, 12.5%-33.7%), which was nearly three times as much lysis as tPA alone (P < 0.001). Conversely, the addition of platelet lysate decreased tPA-mediated fibrinolysis to 0.35% (IQR, 0.2%-0.8%; P < 0.001). Affinity chromatography coupled with tandem mass spectrometry identified a number of proteins not previously associated with regulation of fibrinolysis and trauma.
CONCLUSION: Red blood cell lysate is a potent enhancer of fibrinolysis, whereas platelet lysate inhibits fibrinolysis. Intracellular proteins from circulating blood cells contain proteins that interact with the two key proteins of tPA-mediated fibrinolysis. Understanding the effect of tissue injury and shock on the lysis of circulating cells may provide insight to comprehending the spectrum of fibrinolysis in response to trauma.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25072794      PMCID: PMC4373619          DOI: 10.1097/SHK.0000000000000245

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  35 in total

Review 1.  Thrombelastography.

Authors:  N Salooja; D J Perry
Journal:  Blood Coagul Fibrinolysis       Date:  2001-07       Impact factor: 1.276

2.  Mouse cell lines that use heat shock promoters to regulate the expression of tissue plasminogen activator.

Authors:  M M Bendig; P E Stephens; M I Cockett; C C Hentschel
Journal:  DNA       Date:  1987-08

3.  Treatment of severe acute respiratory distress syndrome: a final report on a phase I study.

Authors:  R M Hardaway; H Harke; A H Tyroch; C H Williams; Y Vazquez; G F Krause
Journal:  Am Surg       Date:  2001-04       Impact factor: 0.688

4.  Fibrinolysis.

Authors:  G R Fearnley
Journal:  Ann R Coll Surg Engl       Date:  1967-07       Impact factor: 1.891

5.  Reaction pattern to three stresses--electroplexy, surgery, and myocardial infarction--of fibrinolysis and plasma fibrinogen.

Authors:  R Chakrabarti; E D Hocking; G R Fearnley
Journal:  J Clin Pathol       Date:  1969-11       Impact factor: 3.411

6.  Evidence that meizothrombin is an intermediate product in the clotting of whole blood.

Authors:  E G Bovill; R P Tracy; T E Hayes; R J Jenny; F H Bhushan; K G Mann
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-06       Impact factor: 8.311

7.  Fibrinogen-independent aggregation and deaggregation of human platelets: studies in two afibrinogenemic patients.

Authors:  M Cattaneo; R L Kinlough-Rathbone; A Lecchi; C Bevilacqua; M A Packham; J F Mustard
Journal:  Blood       Date:  1987-07       Impact factor: 22.113

8.  Effect of heat shock on the expression of urokinase-type plasminogen activator receptor in human umbilical vein endothelial cells.

Authors:  H Fukao; Y Hagiya; S Ueshima; K Okada; T Takaishi; S Izaki; O Matsuo
Journal:  Thromb Haemost       Date:  1996-02       Impact factor: 5.249

9.  Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions.

Authors:  Judith A Coppinger; Gerard Cagney; Sinead Toomey; Thomas Kislinger; Orina Belton; James P McRedmond; Dolores J Cahill; Andrew Emili; Desmond J Fitzgerald; Patricia B Maguire
Journal:  Blood       Date:  2003-11-20       Impact factor: 22.113

10.  Evidence that postoperative fibrinolytic shutdown is mediated by plasma factors that stimulate endothelial cell type I plasminogen activator inhibitor biosynthesis.

Authors:  J Kassis; J Hirsh; T J Podor
Journal:  Blood       Date:  1992-10-01       Impact factor: 22.113

View more
  31 in total

Review 1.  Postinjury fibrinolysis shutdown: Rationale for selective tranexamic acid.

Authors:  Ernest E Moore; Hunter B Moore; Eduardo Gonzalez; Michael P Chapman; Kirk C Hansen; Angela Sauaia; Christopher C Silliman; Anirban Banerjee
Journal:  J Trauma Acute Care Surg       Date:  2015-06       Impact factor: 3.313

2.  Rationale for the selective administration of tranexamic acid to inhibit fibrinolysis in the severely injured patient.

Authors:  Ernest E Moore; Hunter B Moore; Eduardo Gonzalez; Angela Sauaia; Anirban Banerjee; Christopher C Silliman
Journal:  Transfusion       Date:  2016-04       Impact factor: 3.157

3.  Plasma is the physiologic buffer of tissue plasminogen activator-mediated fibrinolysis: rationale for plasma-first resuscitation after life-threatening hemorrhage.

Authors:  Hunter B Moore; Ernest E Moore; Eduardo Gonzalez; Gregory Wiener; Michael P Chapman; Monika Dzieciatkowska; Angela Sauaia; Anirban Banerjee; Kirk C Hansen; Christopher Silliman
Journal:  J Am Coll Surg       Date:  2015-03-31       Impact factor: 6.113

4.  Increase in post-reperfusion sensitivity to tissue plasminogen activator-mediated fibrinolysis during liver transplantation is associated with abnormal metabolic changes and increased blood product utilisation.

Authors:  Hunter B Moore; Angelo D'Alessandro; Ernest E Moore; Matthew Wither; Peter J Lawson; Benjamin R Huebner; Kirk Hansen; Rashikh Choudhury; Trevor L Nydam
Journal:  Blood Transfus       Date:  2019-02-04       Impact factor: 3.443

Review 5.  The accumulation of lipids and proteins during red blood cell storage: the roles of leucoreduction and experimental filtration.

Authors:  Christopher C Silliman; Timothy Burke; Marguerite R Kelher
Journal:  Blood Transfus       Date:  2017-03       Impact factor: 3.443

6.  Fibrinolysis shutdown phenotype masks changes in rodent coagulation in tissue injury versus hemorrhagic shock.

Authors:  Hunter B Moore; Ernest E Moore; Peter J Lawson; Eduardo Gonzalez; Miguel Fragoso; Alex P Morton; Fabia Gamboni; Michael P Chapman; Angela Sauaia; Anirban Banerjee; Christopher C Silliman
Journal:  Surgery       Date:  2015-06-05       Impact factor: 3.982

7.  Human neutrophil elastase mediates fibrinolysis shutdown through competitive degradation of plasminogen and generation of angiostatin.

Authors:  Christopher D Barrett; Hunter B Moore; Anirban Banerjee; Christopher C Silliman; Ernest E Moore; Michael B Yaffe
Journal:  J Trauma Acute Care Surg       Date:  2017-12       Impact factor: 3.313

Review 8.  The current understanding of trauma-induced coagulopathy (TIC): a focused review on pathophysiology.

Authors:  Stefano Giordano; Luca Spiezia; Elena Campello; Paolo Simioni
Journal:  Intern Emerg Med       Date:  2017-05-05       Impact factor: 3.397

9.  Systemic hyperfibrinolysis after trauma: a pilot study of targeted proteomic analysis of superposed mechanisms in patient plasma.

Authors:  Anirban Banerjee; Christopher C Silliman; Ernest E Moore; Monika Dzieciatkowska; Marguerite Kelher; Angela Sauaia; Kenneth Jones; Michael P Chapman; Eduardo Gonzalez; Hunter B Moore; Angelo D'Alessandro; Erik Peltz; Benjamin E Huebner; Peter Einerson; James Chandler; Arsen Ghasabayan; Kirk Hansen
Journal:  J Trauma Acute Care Surg       Date:  2018-06       Impact factor: 3.313

10.  Viscoelastic measurements of platelet function, not fibrinogen function, predicts sensitivity to tissue-type plasminogen activator in trauma patients.

Authors:  H B Moore; E E Moore; M P Chapman; E Gonzalez; A L Slaughter; A P Morton; A D'Alessandro; K C Hansen; A Sauaia; A Banerjee; C C Silliman
Journal:  J Thromb Haemost       Date:  2015-09-22       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.